» Authors » Lisa Block

Lisa Block

Explore the profile of Lisa Block including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 272
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marukutira T, Ussery F, Kadima E, Mills L, Moore J, Block L, et al.
PLoS One . 2022 Jun; 17(6):e0269178. PMID: 35704556
Introduction: Voluntary medical male circumcision (VMMC) uptake has been slow in some countries, including Botswana. To inform demand creation efforts, we examined sociodemographic characteristics and referral procedures associated with VMMC...
2.
Ussery F, Bachanas P, Alwano M, Lebelonyane R, Block L, Wirth K, et al.
J Acquir Immune Defic Syndr . 2022 May; 91(1):9-16. PMID: 35537094
Background And Setting: The Botswana Combination Prevention Project demonstrated a 30% reduction in community HIV incidence through expanded HIV testing, enhanced linkage to care, and universal antiretroviral treatment and exceeded...
3.
Block L, Pfaff M, Harris A, Goldstein J, Losee J
Plast Reconstr Surg . 2022 Mar; 149(4):779e-788e. PMID: 35349547
Learning Objectives: After studying this article, the participant should be able to: (1) Preoperatively evaluate the patient with a crooked nose. (2) Develop a comprehensive preoperative plan specific to the...
4.
Lebelonyane R, Bachanas P, Block L, Ussery F, Alwano M, Marukutira T, et al.
PLoS One . 2021 Aug; 16(8):e0255227. PMID: 34375343
Background: Increasing HIV treatment coverage is crucial to reducing population-level HIV incidence. Methods: The Botswana Combination Prevention Project (BCPP) was a community randomized trial examining the impact of multiple prevention...
5.
Bachanas P, Alwano M, Lebelonyane R, Block L, Behel S, Raizes E, et al.
PLoS One . 2021 Apr; 16(4):e0250211. PMID: 33882092
Introduction: The scale-up of Universal Test and Treat has resulted in reductions in HIV morbidity, mortality and incidence. However, healthcare system and personal challenges have impacted the levels of treatment...
6.
Lebelonyane R, Bachanas P, Block L, Ussery F, Abrams W, Roland M, et al.
Lancet HIV . 2020 Aug; 7(8):e545-e553. PMID: 32763218
Background: Ensuring that individuals who are living with HIV rapidly initiate antiretroviral therapy (ART) is an essential step in meeting the 90-90-90 targets. We evaluated the feasibility and outcomes of...
7.
Lebelonyane R, Mills L, Mogorosi C, Ussery F, Marukutira T, Theu J, et al.
AIDS . 2020 Jul; 34(15):2223-2230. PMID: 32694412
Objective(s): To determine the proportion of individuals linking to HIV-care with advanced HIV-disease (CD4 cell counts ≤200 cells/μl) in the Botswana Combination Prevention Project, describe the characteristics of these individuals,...
8.
Wirth K, Gaolathe T, Pretorius Holme M, Mmalane M, Kadima E, Chakalisa U, et al.
Lancet HIV . 2020 Jun; 7(6):e422-e433. PMID: 32504575
Background: In settings with high HIV prevalence and treatment coverage, such as Botswana, it is unknown whether uptake of HIV prevention and treatment interventions can be increased further. We sought...
9.
Alwano M, Bachanas P, Block L, Roland M, Sento B, Behel S, et al.
PLoS One . 2019 Nov; 14(11):e0225076. PMID: 31765394
Introduction: Achieving widespread knowledge of HIV-positive status is a crucial step to reaching universal ART coverage, population level viral suppression, and ultimately epidemic control. We implemented a multi-modality HIV testing...
10.
Marukutira T, Block L, Alwano M, Behel S, Jarvis J, Chakalisa U, et al.
PLoS One . 2019 Aug; 14(8):e0221629. PMID: 31465494
Introduction: Non-citizens often face barriers to HIV care and treatment. Quantifying knowledge of positive HIV status and antiretroviral therapy (ART) coverage among non-citizens in a high HIV-prevalence country like Botswana...